Literature DB >> 1463467

Possible multifunction of glucose transporter. Transport of nicotinamide by reconstituted liposomes.

M Sofue1, Y Yoshimura, M Nishida, J Kawada.   

Abstract

A kinetic study of the uptake of nicotinamide by reconstituted liposomes containing the human erythrocyte glucose transporter, compared with that of D-glucose, demonstrated that the Km and Vmax. values were almost the same for each compound, and that the uptake of D-glucose was competitively inhibited by nicotinamide. At 20 mM concentration, 2-deoxy-D-glucose, 3-O-methyl-D-glucose and 4,6-O-ethylidene-D-glucose all caused 50% inhibition of nicotinamide uptake, but L-glucose and nicotinic acid were not inhibitory. Similar results were obtained for the uptake of D-glucose. Cytochalasin B binding to the liposomes was inhibited in a dose-dependent manner by either nicotinamide or D-glucose. Antibody for glucose transporter detected in band 4.5 by SDS/PAGE inhibited the uptake of D-glucose and nicotinamide. A possible uptake of nicotinamide by nucleoside transporter was excluded. In human erythrocytes, cytochalasin B binding was inhibited dose-dependently by either nicotinamide or D-glucose, and cytochalasin B depressed the uptake of both nicotinamide and 2-deoxy-D-glucose. These findings were well reproduced in the reconstituted liposomes. The very close similarities between uptake of nicotinamide and D-glucose suggest that the glucose transporter plays a direct role in transport of nicotinamide, which is structurally quite different from monosaccharides, and thus that the transporter is probably multifunctional.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1463467      PMCID: PMC1132063          DOI: 10.1042/bj2880669

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  23 in total

1.  The determination of enzyme inhibitor constants.

Authors:  M DIXON
Journal:  Biochem J       Date:  1953-08       Impact factor: 3.857

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Reconstitution and purification of the D-glucose transporter from human erythrocytes.

Authors:  M Kasahara; P C Hinkle
Journal:  J Biol Chem       Date:  1977-10-25       Impact factor: 5.157

Review 4.  Nucleoside transport in animal cells.

Authors:  J D Young; S M Jarvis
Journal:  Biosci Rep       Date:  1983-04       Impact factor: 3.840

5.  Spatial requirements for insulin-sensitive sugar transport in rat adipocytes.

Authors:  G D Holman; E J Pierce; W D Rees
Journal:  Biochim Biophys Acta       Date:  1981-09-07

6.  The monosaccharide transport system of the human erythrocyte. Orientation upon reconstitution.

Authors:  J M Baldwin; G E Lienhard; S A Baldwin
Journal:  Biochim Biophys Acta       Date:  1980-07

7.  Reconstitution studies of the human erythrocyte nucleoside transporter.

Authors:  C M Tse; J A Belt; S M Jarvis; A R Paterson; J S Wu; J D Young
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

8.  Inhibition of ribonucleoside metabolism in Ehrlich ascites tumor cells by purine analogue ribonucleosides.

Authors:  A R Paterson; A I Simpson
Journal:  Can J Biochem       Date:  1965-10

9.  Erythrocyte nucleoside transport: asymmetrical binding of nitrobenzylthioinosine to nucleoside permeation sites.

Authors:  S M Jarvis; D McBride; J D Young
Journal:  J Physiol       Date:  1982-03       Impact factor: 5.182

10.  Nicotinamide and other inhibitors of ADP-ribosylation block deoxyglucose uptake in cultured cells.

Authors:  C Grunfeld; J K Shigenaga
Journal:  Biochem Biophys Res Commun       Date:  1984-09-17       Impact factor: 3.575

View more
  4 in total

1.  Defective glucose transport across brain tissue barriers: a newly recognized neurological syndrome.

Authors:  J Klepper; D Wang; J Fischbarg; J C Vera; I T Jarjour; K R O'Driscoll; D C De Vivo
Journal:  Neurochem Res       Date:  1999-04       Impact factor: 3.996

2.  Evidence that facilitative glucose transporters may fold as beta-barrels.

Authors:  J Fischbarg; M Cheung; F Czegledy; J Li; P Iserovich; K Kuang; J Hubbard; M Garner; O M Rosen; D W Golde
Journal:  Proc Natl Acad Sci U S A       Date:  1993-12-15       Impact factor: 11.205

3.  ADP modifies the function of the glucose transporter: studies with reconstituted liposomes.

Authors:  M Sofue; Y Yoshimura; M Nishida; J Kawada
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

4.  Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedules.

Authors:  J Murray; H Thomas; P Berry; S Kyle; M Patterson; C Jones; G Los; Z Hostomsky; E R Plummer; A V Boddy; N J Curtin
Journal:  Br J Cancer       Date:  2014-02-20       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.